SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Cardiovascular BioTherapeutics, Inc. Submits FDA Application for 'Fast Track' Status for CVBT-141B, CVBT's Biological Treatment for Diabetes Patients